166 related articles for article (PubMed ID: 27566104)
1. Micro-Environmental Stress Induces Src-Dependent Activation of Invadopodia and Cell Migration in Ewing Sarcoma.
Bailey KM; Airik M; Krook MA; Pedersen EA; Lawlor ER
Neoplasia; 2016 Aug; 18(8):480-8. PubMed ID: 27566104
[TBL] [Abstract][Full Text] [Related]
2. Microenvironmental Factors Drive Tenascin C and Src Cooperation to Promote Invadopodia Formation in Ewing Sarcoma.
Hawkins AG; Julian CM; Konzen S; Treichel S; Lawlor ER; Bailey KM
Neoplasia; 2019 Oct; 21(10):1063-1072. PubMed ID: 31521948
[TBL] [Abstract][Full Text] [Related]
3. Dasatinib inhibits migration and invasion in diverse human sarcoma cell lines and induces apoptosis in bone sarcoma cells dependent on SRC kinase for survival.
Shor AC; Keschman EA; Lee FY; Muro-Cacho C; Letson GD; Trent JC; Pledger WJ; Jove R
Cancer Res; 2007 Mar; 67(6):2800-8. PubMed ID: 17363602
[TBL] [Abstract][Full Text] [Related]
4. Stress-induced CXCR4 promotes migration and invasion of ewing sarcoma.
Krook MA; Nicholls LA; Scannell CA; Chugh R; Thomas DG; Lawlor ER
Mol Cancer Res; 2014 Jun; 12(6):953-64. PubMed ID: 24651452
[TBL] [Abstract][Full Text] [Related]
5. β3 integrin expression is required for invadopodia-mediated ECM degradation in lung carcinoma cells.
Peláez R; Morales X; Salvo E; Garasa S; Ortiz de Solórzano C; Martínez A; Larrayoz IM; Rouzaut A
PLoS One; 2017; 12(8):e0181579. PubMed ID: 28767724
[TBL] [Abstract][Full Text] [Related]
6. SRC signaling is crucial in the growth of synovial sarcoma cells.
Michels S; Trautmann M; Sievers E; Kindler D; Huss S; Renner M; Friedrichs N; Kirfel J; Steiner S; Endl E; Wurst P; Heukamp L; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Cancer Res; 2013 Apr; 73(8):2518-28. PubMed ID: 23580575
[TBL] [Abstract][Full Text] [Related]
7. SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration.
Indovina P; Casini N; Forte IM; Garofano T; Cesari D; Iannuzzi CA; Del Porro L; Pentimalli F; Napoliello L; Boffo S; Schenone S; Botta M; Giordano A
J Cell Physiol; 2017 Jan; 232(1):129-35. PubMed ID: 27037775
[TBL] [Abstract][Full Text] [Related]
8. SNARE-dependent interaction of Src, EGFR and β1 integrin regulates invadopodia formation and tumor cell invasion.
Williams KC; Coppolino MG
J Cell Sci; 2014 Apr; 127(Pt 8):1712-25. PubMed ID: 24496451
[TBL] [Abstract][Full Text] [Related]
9. In vitro antiproliferative and antimigratory activity of dasatinib in neuroblastoma and Ewing sarcoma cell lines.
Timeus F; Crescenzio N; Fandi A; Doria A; Foglia L; Cordero di Montezemolo L
Oncol Rep; 2008 Feb; 19(2):353-9. PubMed ID: 18202781
[TBL] [Abstract][Full Text] [Related]
10. Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States.
Pedersen EA; Menon R; Bailey KM; Thomas DG; Van Noord RA; Tran J; Wang H; Qu PP; Hoering A; Fearon ER; Chugh R; Lawlor ER
Cancer Res; 2016 Sep; 76(17):5040-53. PubMed ID: 27364557
[TBL] [Abstract][Full Text] [Related]
11. CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
Hoffmann C; Mao X; Dieterle M; Moreau F; Al Absi A; Steinmetz A; Oudin A; Berchem G; Janji B; Thomas C
Oncotarget; 2016 Mar; 7(12):13688-705. PubMed ID: 26883198
[TBL] [Abstract][Full Text] [Related]
12. The Ewing Sarcoma Secretome and Its Response to Activation of Wnt/beta-catenin Signaling.
Hawkins AG; Basrur V; da Veiga Leprevost F; Pedersen E; Sperring C; Nesvizhskii AI; Lawlor ER
Mol Cell Proteomics; 2018 May; 17(5):901-912. PubMed ID: 29386236
[TBL] [Abstract][Full Text] [Related]
13. The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis.
Sechler M; Parrish JK; Birks DK; Jedlicka P
Oncogene; 2017 Jul; 36(29):4150-4160. PubMed ID: 28319067
[TBL] [Abstract][Full Text] [Related]
14. IL6 secreted by Ewing sarcoma tumor microenvironment confers anti-apoptotic and cell-disseminating paracrine responses in Ewing sarcoma cells.
Lissat A; Joerschke M; Shinde DA; Braunschweig T; Meier A; Makowska A; Bortnick R; Henneke P; Herget G; Gorr TA; Kontny U
BMC Cancer; 2015 Jul; 15():552. PubMed ID: 26215971
[TBL] [Abstract][Full Text] [Related]
15. The Macrophage Inhibitor CNI-1493 Blocks Metastasis in a Mouse Model of Ewing Sarcoma through Inhibition of Extravasation.
Hesketh AJ; Maloney C; Behr CA; Edelman MC; Glick RD; Al-Abed Y; Symons M; Soffer SZ; Steinberg BM
PLoS One; 2015; 10(12):e0145197. PubMed ID: 26709919
[TBL] [Abstract][Full Text] [Related]
16. Cigarette smoke extract exposure induces EGFR-TKI resistance in EGFR-mutated NSCLC via mediating Src activation and EMT.
Li D; Zhang L; Zhou J; Chen H
Lung Cancer; 2016 Mar; 93():35-42. PubMed ID: 26898612
[TBL] [Abstract][Full Text] [Related]
17. STEAP1 is associated with the invasive and oxidative stress phenotype of Ewing tumors.
Grunewald TG; Diebold I; Esposito I; Plehm S; Hauer K; Thiel U; da Silva-Buttkus P; Neff F; Unland R; Müller-Tidow C; Zobywalski C; Lohrig K; Lewandrowski U; Sickmann A; Prazeres da Costa O; Görlach A; Cossarizza A; Butt E; Richter GH; Burdach S
Mol Cancer Res; 2012 Jan; 10(1):52-65. PubMed ID: 22080479
[TBL] [Abstract][Full Text] [Related]
18. Modeling Stroma-Induced Drug Resistance in a Tissue-Engineered Tumor Model of Ewing Sarcoma.
Santoro M; Menegaz BA; Lamhamedi-Cherradi SE; Molina ER; Wu D; Priebe W; Ludwig JA; Mikos AG
Tissue Eng Part A; 2017 Jan; 23(1-2):80-89. PubMed ID: 27923328
[TBL] [Abstract][Full Text] [Related]
19. A Golgi-based KDELR-dependent signalling pathway controls extracellular matrix degradation.
Ruggiero C; Fragassi G; Grossi M; Picciani B; Di Martino R; Capitani M; Buccione R; Luini A; Sallese M
Oncotarget; 2015 Feb; 6(5):3375-93. PubMed ID: 25682866
[TBL] [Abstract][Full Text] [Related]
20. DKK2 mediates osteolysis, invasiveness, and metastatic spread in Ewing sarcoma.
Hauer K; Calzada-Wack J; Steiger K; Grunewald TG; Baumhoer D; Plehm S; Buch T; Prazeres da Costa O; Esposito I; Burdach S; Richter GH
Cancer Res; 2013 Jan; 73(2):967-77. PubMed ID: 23204234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]